ALC:NYSE
Alcon AG
74,67Â USD
arrow_upward
+0,23%(+0,17) 1Â D
20. nov., 12:08:59 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for ALC …
Ă…pne
74,16Â USD
Høy
75,04Â USD
Lav
74,10Â USD
Markedsverdi
31,15Â mrd.
Snittvolum
2,43Â mill.
Volum
1,06Â mill.
52 u høy
87,64Â USD
52Â u lav
61,84Â USD
Beta
0,87
UtestĂ¥ende aksjer
480,40Â mill.
Antall ansatte
25k
Ă…pne
74,16Â USD
Høy
75,04Â USD
Lav
74,10Â USD
Markedsverdi
31,15Â mrd.
Snittvolum
2,43Â mill.
Volum
1,06Â mill.
52 u høy
87,64Â USD
52Â u lav
61,84Â USD
Beta
0,87
UtestĂ¥ende aksjer
480,40Â mill.
Antall ansatte
25k
Nyhetssaker
Fra nettkilder og nyhetspartnere
ad-hoc-news.de
·
for 1 time siden
Alcon stock: Pershing Square takes a $954 million stake
TradingView
·
for 9 timer siden
Alcon Inc. Stock 12‑Month Price Target Raised to $86.4, Implies 16% Upside
Yahoo Finance
·
for 19 timer siden
Why Pershing Square Is Betting Big on Alcon Stock
Zacks
·
for 2 døgn siden
What Drove Glaukos Stock's 48% Rally Since the End of September?
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Om Alcon AG
Administrerende direktørDavid J. Endicott
Ansatte25k
Grunnlagt1945
HovedkontorGenève, Genève, Sveits
SektorHealth Care
Bransje-
Nettstedalcon.com